PFG Investments LLC Purchases 48,000 Shares of Biosig Technologies, Inc. (NASDAQ:BSGM)

PFG Investments LLC raised its holdings in shares of Biosig Technologies, Inc. (NASDAQ:BSGM - Free Report) by 43.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 158,286 shares of the company's stock after purchasing an additional 48,000 shares during the period. PFG Investments LLC owned 0.92% of Biosig Technologies worth $95,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Integrity Wealth Advisors Inc. acquired a new stake in shares of Biosig Technologies during the fourth quarter worth $61,000. Geode Capital Management LLC acquired a new position in Biosig Technologies in the fourth quarter valued at about $143,000. Millennium Management LLC bought a new position in Biosig Technologies during the fourth quarter worth about $228,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of Biosig Technologies during the 4th quarter worth about $5,369,000. Institutional investors own 7.16% of the company's stock.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets increased their price target on shares of Biosig Technologies from $2.50 to $10.00 and gave the company a "buy" rating in a research report on Friday, June 6th.

Biosig Technologies Trading Down 10.0%

BSGM traded down $0.85 during mid-day trading on Friday, hitting $7.66. The stock had a trading volume of 746,642 shares, compared to its average volume of 340,946. Biosig Technologies, Inc. has a 1-year low of $0.23 and a 1-year high of $8.80. The stock's fifty day simple moving average is $4.14 and its 200-day simple moving average is $2.07.

Biosig Technologies (NASDAQ:BSGM - Get Free Report) last released its quarterly earnings data on Monday, May 19th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.09). Equities research analysts anticipate that Biosig Technologies, Inc. will post -0.88 EPS for the current year.

About Biosig Technologies

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.